Evidence map›Paper›PMID 38031174›Full record

ArticleAddiction science & clinical practice2023

Mobile service delivery in response to the opioid epidemic in Philadelphia.

Rebecca E Stewart, Hanna P Christian, Nicholas C Cardamone, Catherine Abrams, Caroline Drob, David S Mandell, David Metzger, Margaret Lowenstein

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mobile addiction treatment units: a narrative review.Addiction science & clinical practice · 2025
    Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca E StewartUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Rebecca.stewart@pennmedicine.upenn.edu.ORCID 0000-0002-6453-6715
Hanna P ChristianUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Nicholas C CardamoneUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Catherine AbramsThe Health Federation of Philadelphia, Philadelphia, PA, USA.
Caroline DrobThe Health Federation of Philadelphia, Philadelphia, PA, USA.
David S MandellUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
David MetzgerUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Margaret LowensteinUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Funding

Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Knashawn Hodge Morales · 2013 to 2026
$23.5M
NIMH NIH HHS P30 MH097488
6 · The paper itself

Abstract

backgroundThe harms of opioid use disorder (OUD) and HIV infection disproportionately impact marginalized populations, especially people experiencing homelessness and people who inject drugs (PWID). Mobile OUD service delivery models are emerging to increase access and reduce barriers to OUD care. While there is growing interest in these models, there is limited research about the services they provide, how they operate, and what barriers they face. We characterize the capacity, barriers, and sustainment of mobile OUD care services in a large city with a high incidence of OUD and HIV.

methodsFrom May to August 2022, we conducted semi-structured interviews with leadership from all seven mobile OUD care units (MOCU) providing a medication for OUD or other substance use disorder services in Philadelphia. We surveyed leaders about their unit's services, staffing, operating location, funding sources, and linkages to care. Leaders were asked to describe their clinical approach, treatment process, and the barriers and facilitators to their operations. Interview recordings were coded using rapid qualitative analysis.

resultsMOCUs are run by small, multidisciplinary teams, typically composed of a clinician, one or two case managers, and a peer recovery specialist or outreach worker. MOCUs provide a range of services, including medications for OUD, wound care, medical services, case management, and screening for infectious diseases. No units provide methadone, but all units provide naloxone, six write prescriptions for buprenorphine, and one unit dispenses buprenorphine. The most frequently reported barriers include practical challenges of working on a MOCU (e.g. lack of space, safety), lack of community support, and patients with substantial medical and psychosocial needs. Interviewees reported concerns about funding and specifically as it relates to providing their staff with adequate pay. The most frequently reported facilitators include positive relationships with the community, collaboration with other entities (e.g. local nonprofits, the police department, universities), and having non-clinical staff (e.g. outreach workers, peer recovery specialists) on the unit.

conclusionsMOCUs provide life-saving services and engage marginalized individuals with OUD. These findings highlight the challenges and complexities of caring for PWID and demonstrate a need to strengthen collaborations between MOCU providers and the treatment system. Policymakers should consider programmatic funding for permanent mobile OUD care services.

Indexed as

BuprenorphineHIV InfectionsOpioid-Related DisordersSubstance Abuse, IntravenousAnalgesics, OpioidHumansOpiate Substitution TreatmentOpioid EpidemicPhiladelphiaAnalgesics, OpioidBuprenorphineBuprenorphineHIV preventionLow barrier treatment modelMobile treatmentOpioid use disorderPWID

Identifiers

PMID38031174
PMCPMC10687974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.